For research use only. Not for therapeutic Use.
| Catalog Number | R067959 |
| Synonyms | N-C19:0-Sulfatide; N-Nonadecanoyl-sphingosyl-beta-D-galactoside-3-sulfate |
| Molecular Formula | C43H83NO11S |
| Purity | ≥95% |
| Solubility | DMSO, DMF, chloroform/methanol, 5:1 |
| Storage | Store at -20°C |
| Reference | 1. H. Cheng, Y. Zhou, D. M. Holtzman, X. Han “Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer/’s disease.” Neurobiology of Aging August 20082. Ramesh C. Halder, A. Jahng, I. Maricic and Vipin Kumar “Mini Review: Immune Response to Myelin-Derived Sulfatide and CNS-Demyelination” Neurochemical Research, February, Vol. 32(2): 257, 20073. Phillip D. Whitfield, Peter C. Sharp, David W. Johnson, Paul Nelson and Peter J. Meikle “Characterization of Urinary Sulfatides in Metachromatic Leukodystrophy Using Electrospray Ionization-Tandem Mass Spectrometry” Molecular Genetics and Metabolism, May Vol. 73(1): 30, 20014. A. Winzeler et al. “The Lipid Sulfatide Is a Novel Myelin-Associated Inhibitor of CNS Axon Outgrowth” The Journal of Neuroscience, vol. 31 pp. 6481-6492, 20115. D. Zajonc et al. “Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity” The Journal of Experimental Medicine, vol. 202 pp. 1517-1526, 2005 |
